Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma Screening

Jianghong Guo, Jing Li, Jiang Chang, Li Wang, Yanfeng Xi Department of Pathology, Cancer Hospital Affiliated to Shanxi Medical University, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Taiyuan, People’s Republic of ChinaCorrespon...

Full description

Bibliographic Details
Main Authors: Guo J, Li J, Chang J, Wang L, Xi Y
Format: Article
Language:English
Published: Dove Medical Press 2023-02-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/value-of-methylation-status-of-rprm-sdc2-and-tcf4-genes-in-plasma-for--peer-reviewed-fulltext-article-IJGM
_version_ 1797894480432463872
author Guo J
Li J
Chang J
Wang L
Xi Y
author_facet Guo J
Li J
Chang J
Wang L
Xi Y
author_sort Guo J
collection DOAJ
description Jianghong Guo, Jing Li, Jiang Chang, Li Wang, Yanfeng Xi Department of Pathology, Cancer Hospital Affiliated to Shanxi Medical University, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Taiyuan, People’s Republic of ChinaCorrespondence: Yanfeng Xi, Email xiyanfeng1998@163.comObjective: To explore the clinical value of the combined screening of the methylation statuses of the RPRM, SDC2, and TCF4 genes in plasma of gastric cancer patients.Methods: Differential expressed genes (DEGs) were selected from the Gene Expression Omnibus database, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed using DAVID, and a protein-protein interaction network was constructed. Hub genes were obtained using Cytoscape. Screening results combined with literature reports identified three genes (RPRM, SDC2, and TCF4). Further analysis was done using biopsies collected through gastroscopy at Shanxi Cancer Hospital from January 8, 2020 to February 22, 2021. The patients were divided into two groups: gastric adenocarcinoma group, and control group which are not gastric adenocarcinoma according to pathological or gastroscopic results. The methylation statuses of the three genes in peripheral blood plasma were detected by fluorescence polymerase chain reaction, and the relationships between the positive rates of the three combined genes with pathology and/or gastroscopy results were analyzed. The clinical value of the combined detection of the three genes was evaluated according to these indicators. The diagnostic specificity and sensitivity of this detective method were analyzed.Results: A total of 197 DEGs were identified and 12 hub genes were obtained. The enriched functions and pathways of DEGs include regulation of cell proliferation, extracellular space, cytokine activity, and pathways in cancer. The combination of RPRM, SDC2, and TCF4 gene methylation had a specificity of 93.39% and sensitivity of 80.33%. The combined positive rate of RPRM, SDC2, and TCF4 gene methylation in patients with gastric adenocarcinoma was significantly higher compared with those without gastric adenocarcinoma (χ2=151.179, P< 0.05).Conclusion: Combined detection of RPRM, SDC2, and TCF4 gene methylation in peripheral blood plasma maybe helpful in screening for gastric adenocarcinoma, and maybe a complementary method to gastroscopy and serum tumor markers.Keywords: gastric cancer, RPRM, SDC2, TCF4, methylation
first_indexed 2024-04-10T07:09:42Z
format Article
id doaj.art-b5632b1e488e41509adab3d767755af2
institution Directory Open Access Journal
issn 1178-7074
language English
last_indexed 2024-04-10T07:09:42Z
publishDate 2023-02-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj.art-b5632b1e488e41509adab3d767755af22023-02-26T15:41:34ZengDove Medical PressInternational Journal of General Medicine1178-70742023-02-01Volume 1667368181826Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma ScreeningGuo JLi JChang JWang LXi YJianghong Guo, Jing Li, Jiang Chang, Li Wang, Yanfeng Xi Department of Pathology, Cancer Hospital Affiliated to Shanxi Medical University, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Taiyuan, People’s Republic of ChinaCorrespondence: Yanfeng Xi, Email xiyanfeng1998@163.comObjective: To explore the clinical value of the combined screening of the methylation statuses of the RPRM, SDC2, and TCF4 genes in plasma of gastric cancer patients.Methods: Differential expressed genes (DEGs) were selected from the Gene Expression Omnibus database, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed using DAVID, and a protein-protein interaction network was constructed. Hub genes were obtained using Cytoscape. Screening results combined with literature reports identified three genes (RPRM, SDC2, and TCF4). Further analysis was done using biopsies collected through gastroscopy at Shanxi Cancer Hospital from January 8, 2020 to February 22, 2021. The patients were divided into two groups: gastric adenocarcinoma group, and control group which are not gastric adenocarcinoma according to pathological or gastroscopic results. The methylation statuses of the three genes in peripheral blood plasma were detected by fluorescence polymerase chain reaction, and the relationships between the positive rates of the three combined genes with pathology and/or gastroscopy results were analyzed. The clinical value of the combined detection of the three genes was evaluated according to these indicators. The diagnostic specificity and sensitivity of this detective method were analyzed.Results: A total of 197 DEGs were identified and 12 hub genes were obtained. The enriched functions and pathways of DEGs include regulation of cell proliferation, extracellular space, cytokine activity, and pathways in cancer. The combination of RPRM, SDC2, and TCF4 gene methylation had a specificity of 93.39% and sensitivity of 80.33%. The combined positive rate of RPRM, SDC2, and TCF4 gene methylation in patients with gastric adenocarcinoma was significantly higher compared with those without gastric adenocarcinoma (χ2=151.179, P< 0.05).Conclusion: Combined detection of RPRM, SDC2, and TCF4 gene methylation in peripheral blood plasma maybe helpful in screening for gastric adenocarcinoma, and maybe a complementary method to gastroscopy and serum tumor markers.Keywords: gastric cancer, RPRM, SDC2, TCF4, methylationhttps://www.dovepress.com/value-of-methylation-status-of-rprm-sdc2-and-tcf4-genes-in-plasma-for--peer-reviewed-fulltext-article-IJGMgastric cancerrprmsdc2tcf4methylation
spellingShingle Guo J
Li J
Chang J
Wang L
Xi Y
Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma Screening
International Journal of General Medicine
gastric cancer
rprm
sdc2
tcf4
methylation
title Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma Screening
title_full Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma Screening
title_fullStr Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma Screening
title_full_unstemmed Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma Screening
title_short Value of Methylation Status of RPRM, SDC2, and TCF4 Genes in Plasma for Gastric Adenocarcinoma Screening
title_sort value of methylation status of rprm sdc2 and tcf4 genes in plasma for gastric adenocarcinoma screening
topic gastric cancer
rprm
sdc2
tcf4
methylation
url https://www.dovepress.com/value-of-methylation-status-of-rprm-sdc2-and-tcf4-genes-in-plasma-for--peer-reviewed-fulltext-article-IJGM
work_keys_str_mv AT guoj valueofmethylationstatusofrprmsdc2andtcf4genesinplasmaforgastricadenocarcinomascreening
AT lij valueofmethylationstatusofrprmsdc2andtcf4genesinplasmaforgastricadenocarcinomascreening
AT changj valueofmethylationstatusofrprmsdc2andtcf4genesinplasmaforgastricadenocarcinomascreening
AT wangl valueofmethylationstatusofrprmsdc2andtcf4genesinplasmaforgastricadenocarcinomascreening
AT xiy valueofmethylationstatusofrprmsdc2andtcf4genesinplasmaforgastricadenocarcinomascreening